More information on Vaccine Summit
Vaccine Summit 2012:
With the ever evolving WHO prequalification requirements and complex global regulatory framework, now is the right time for vaccines manufacturers to learn how to cope with these complex regulatory demands, leverage the latest manufacturing technologies, learn about innovative products that will drive the market growth and formulate successful commercialisation strategies.
Don’t miss out on this must-attend conference that will delve to deep into:
•Understand the framework for WHO pre-qualification
• Clarify critical global cGMP requirements
Innovation in Vaccines
•Latest developments, innovations and R&D in pneumococcal conjugate, HPV, HIV, TB, Malaria, Chikungunya, combination vaccines, Rotavirus, Dengue, Thermostable vaccines, fractional dosing, novel adjuvants
Clinical Trials and Clinical Development Challenges
• Global GCP Compliance
• Risk Management strategies for clinical trials
• Age de-escalation strategy in vaccine clinical trials
• Upstream, downstream and scale-up issues
•Challenges in technology transfer
•Robust cold chain management system
Vaccine Commercialisation Strategies
• Brand-building in private markets
•Non UN Healthcare supported public markets
•Commercialise vaccines with specific intricacies of catering to Donor Markets (UNICEF / PAHO) .
A full day program focused on regulatory framework in the emerging markets and rest of the world countries
Shreemanta K Parida,V D Ramanathan,Ramesh Matur,S K Jana,Shafi Kolhapure,Raman Rao,Rajat Goyal, V S Chauhan, Satish Kaipilyawar and many more.